Pancreatic Polypeptide
Also known as: Pancreatic polypeptide, Pancreatic polypeptide hormone, PP, PPoma marker, PPY
Source Pancreatic Polypeptide at Peptiology
Save 10% with code PEPTI-BOSSRABBIT-10
Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.
Summary
Pancreatic polypeptide (PP) is a 36‑amino‑acid hormone secreted by pancreatic F cells; it regulates gastrointestinal motility, pancreatic secretion, and energy balance. Investigational use includes obesity and diabetes management.
Mechanism of Action
Activates neuropeptide Y Y4 (PPY) receptor, inhibiting pancreatic exocrine secretion, modulating hepatic glycogenolysis and promoting satiety
Routes of Administration
Goals & Uses
- Reduction of pancreatic exocrine secretionGastrointestinalModerate
- Gastroparesis symptom controlGastrointestinalLow
- Biomarker for pancreatic neuroendocrine tumorsOncology / DiagnosticsHigh
- Appetite suppression / weight lossMetabolic / ObesityModerate
- Type 2 diabetes adjunctMetabolicLow
- Treatment of Prader-Willi syndrome hyperphagiaRare Disease / MetabolicLow
- Obesity treatmentMetabolicModerate
- Gastroparesis / gastric motility modulationGastrointestinalLow
Contraindications
- Hypersensitivity to pancreatic polypeptide or excipientsAllergyHigh
- Severe hepatic impairmentOrganModerateLiver function concerns
- Severe renal impairmentOrganModerateKidney function concerns
- PregnancyPopulationModeratePotential fetal risk or insufficient safety data
Adverse Effects
- HypoglycemiaMetabolicRareAbnormally low blood glucose
- Injection site reactionsLocalUncommon
- NauseaGastrointestinalUncommonFeeling of sickness or urge to vomit
- Reduced gastric motilityGastrointestinalCommon
- Injection site erythemaLocalCommonRedness at the injection site
- DizzinessNeurologicRareFeeling faint, lightheaded, or unsteady
Drug Interactions
- OctreotideModerate
- Insulin / Hypoglycemic agentsLow
- Anticholinergic agentsLow
Population Constraints
- Pediatric populationsAgeRelative
- Patients with known PPomasOncologyRelative
- PediatricAgeRelative
- Patients with anorexia nervosaEating DisordersRelative
- Pregnant womenReproductiveRelative
Regulatory Status
- European UnionInvestigationalSimilar status as US
- United StatesInvestigationalNo FDA‑approved therapeutic product; used in clinical trials
- United KingdomUnapprovedNo MHRA-approved therapeutic indication. Used as biomarker and research tool.
No approved therapeutic indication in any major jurisdiction. Pancreatic Polypeptide is used as a research and investigational compound. Endogenous PP is measured clinically as a biomarker for pancreatic endocrine function and neuroendocrine tumors (PPomas).
Evidence & Sources
No sources recorded yet.
Frequently Asked Questions
What is Pancreatic Polypeptide?
Pancreatic polypeptide (PP) is a 36‑amino‑acid hormone secreted by pancreatic F cells; it regulates gastrointestinal motility, pancreatic secretion, and energy balance. Investigational use includes obesity and diabetes management.
What is Pancreatic Polypeptide used for?
Pancreatic Polypeptide is educationally associated with: Reduction of pancreatic exocrine secretion, Gastroparesis symptom control, Biomarker for pancreatic neuroendocrine tumors, Appetite suppression / weight loss, Type 2 diabetes adjunct, Treatment of Prader-Willi syndrome hyperphagia, Obesity treatment, Gastroparesis / gastric motility modulation. Educational only — not medical advice.
How is Pancreatic Polypeptide administered?
Recorded routes of administration: Intranasal, Intravenous, Subcutaneous.
What are the potential side effects of Pancreatic Polypeptide?
Reported adverse effects include: Hypoglycemia, Injection site reactions, Nausea, Reduced gastric motility, Injection site erythema, Dizziness. This list is not exhaustive — consult a qualified clinician.
Who should avoid Pancreatic Polypeptide?
Recorded contraindications: Hypersensitivity to pancreatic polypeptide or excipients, Severe hepatic impairment, Severe renal impairment, Pregnancy. Consult a qualified clinician before use.